Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Genomics ; 10: 501, 2009 Oct 29.
Article in English | MEDLINE | ID: mdl-19874620

ABSTRACT

BACKGROUND: New and improved antimicrobial countermeasures are urgently needed to counteract increased resistance to existing antimicrobial treatments and to combat currently untreatable or new emerging infectious diseases. We demonstrate that computational comparative genomics, together with experimental screening, can identify potential generic (i.e., conserved across multiple pathogen species) and novel virulence-associated genes that may serve as targets for broad-spectrum countermeasures. RESULTS: Using phylogenetic profiles of protein clusters from completed microbial genome sequences, we identified seventeen protein candidates that are common to diverse human pathogens and absent or uncommon in non-pathogens. Mutants of 13 of these candidates were successfully generated in Yersinia pseudotuberculosis and the potential role of the proteins in virulence was assayed in an animal model. Six candidate proteins are suggested to be involved in the virulence of Y. pseudotuberculosis, none of which have previously been implicated in the virulence of Y. pseudotuberculosis and three have no record of involvement in the virulence of any bacteria. CONCLUSION: This work demonstrates a strategy for the identification of potential virulence factors that are conserved across a number of human pathogenic bacterial species, confirming the usefulness of this tool.


Subject(s)
Anti-Infective Agents/pharmacology , Virulence/drug effects , Virulence/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Drug Discovery , Drug Resistance, Bacterial , Genomics , Humans , Yersinia pseudotuberculosis/genetics , Yersinia pseudotuberculosis/pathogenicity
2.
PLoS One ; 2(8): e801, 2007 Aug 29.
Article in English | MEDLINE | ID: mdl-17726531

ABSTRACT

BACKGROUND: DNA adenine methylation plays an important role in several critical bacterial processes including mismatch repair, the timing of DNA replication and the transcriptional control of gene expression. The dependence of bacterial virulence on DNA adenine methyltransferase (Dam) has led to the proposal that selective Dam inhibitors might function as broad spectrum antibiotics. METHODOLOGY/PRINCIPAL FINDINGS: Herein we report the expression and purification of Yersinia pestis Dam and the development of a continuous fluorescence based assay for DNA adenine methyltransferase activity that is suitable for determining the kinetic parameters of the enzyme and for high throughput screening against potential Dam inhibitors. The assay utilised a hemimethylated break light oligonucleotide substrate containing a GATC methylation site. When this substrate was fully methylated by Dam, it became a substrate for the restriction enzyme DpnI, resulting in separation of fluorophore (fluorescein) and quencher (dabcyl) and therefore an increase in fluorescence. The assays were monitored in real time using a fluorescence microplate reader in 96 well format and were used for the kinetic characterisation of Yersinia pestis Dam, its substrates and the known Dam inhibitor, S-adenosylhomocysteine. The assay has been validated for high throughput screening, giving a Z-factor of 0.71+/-0.07 indicating that it is a sensitive assay for the identification of inhibitors. CONCLUSIONS/SIGNIFICANCE: The assay is therefore suitable for high throughput screening for inhibitors of DNA adenine methyltransferases and the kinetic characterisation of the inhibition.


Subject(s)
Bacterial Proteins/chemistry , DNA Modification Methylases/chemistry , Oligonucleotides/chemistry , Yersinia pestis/enzymology , Bacterial Proteins/metabolism , DNA Methylation , DNA Modification Methylases/metabolism , DNA, Bacterial/metabolism , Kinetics , Oligonucleotides/metabolism , Substrate Specificity , Yersinia pestis/metabolism
3.
Proteomics ; 7(13): 2172-83, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17533643

ABSTRACT

Stimulation of protective immune responses against intracellular pathogens is difficult to achieve using non-replicating vaccines. BALB/c mice immunized by intramuscular injection with killed Francisella tularensis (live vaccine strain) adjuvanted with preformed immune stimulating complexes admixed with CpG, were protected when systemically challenged with a highly virulent strain of F. tularensis (Schu S4). Serum from immunized mice was used to probe a whole proteome microarray in order to identify immunodominant antigens. Eleven out of the top 12 immunodominant antigens have been previously described as immunoreactive in F. tularensis. However, 31 previously unreported immunoreactive antigens were revealed using this approach. Twenty four (50%) of the ORFs on the immunodominant hit list belonged to the category of surface or membrane associated proteins compared to only 22% of the entire proteome. There were eight hypothetical protein hits and eight hits from proteins associated with different aspects of metabolism. The chip also allowed us to readily determine the IgG subclass bias, towards individual or multiple antigens, in protected and unprotected animals. These data give insight into the protective immune response and have potentially important implications for the rational design of non-living vaccines for tularemia and other intracellular pathogens.


Subject(s)
Francisella tularensis/immunology , Immunodominant Epitopes/analysis , Protein Array Analysis/methods , Proteomics/methods , Adjuvants, Immunologic , Aluminum Hydroxide/immunology , Animals , Bacterial Proteins/immunology , Bacterial Proteins/metabolism , Female , Francisella tularensis/metabolism , ISCOMs/immunology , Immunodominant Epitopes/immunology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Interferon-gamma/metabolism , Interleukin-2/metabolism , Interleukin-4/metabolism , Mice , Mice, Inbred BALB C , Oligodeoxyribonucleotides/immunology , Proteome/immunology , Proteome/metabolism , Spleen/cytology , Spleen/immunology , Survival Analysis , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Tularemia/immunology , Tularemia/microbiology , Tularemia/prevention & control , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...